Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
UC Davis Dedicates Biophotonics Center
The University of California, Davis (U.C. Davis) dedicated the $20-million Center for Biophotonics Science and Technology on January 30, 2006. Located in the Oak Park Research Building in Sacramento, Calif., the 40,000-sf facility will accommodate 100 researchers from U.C. Davis and other partner institutions including U.C. Berkeley, U.C. San Francisco, Stanford University, Mills College, and Lawrence Livermore Laboratory.
National Interagency Biodefense Campus Developed at Fort Detrick
Construction of the National Interagency Biodefense Campus (NIBC) is underway at Fort Detrick in Frederick, Maryland. A collaboration of the U.S. Departments of Defense, Homeland Security, Agriculture, and Health and Human Services, the 200-acre site will be developed over the next six years. Construction of the National Institute of Allergy and Infectious Diseases Integrated Research Facility began in summer of 2005 and is slated for completion in December 2007.
Novartis Expands East Hanover Headquarters
Novartis broke ground in July 2005 on a $116-million expansion of its East Hanover, N.J., headquarters campus. Two 144,000-sf facilities will be constructed, the first reaching completion in October of 2006, the second in May of 2007.
University of Maryland Constructs Biosciences Research Building
The University of Maryland is constructing a new $69-million biosciences research facility on its College Park campus. The building will house research in genomic biology, neurosciences, plant sciences, and host-pathogen interactions. Accommodating the departments of biology, cell biology, genetics, and molecular biology departments for the College of Chemical and Life Sciences, the facility will feature a lecture hall with over 400 seats. The project began construction in September 2004 and is slated for completion in late summer of 2006.
Pfizer Constructs New Jersey Facilities
Pfizer is planning a three-phase expansion of its New Jersey operations. Phase one is comprised of construction of a $218.5-million, 250,000-sf research and development building in Morris Plains. Phase two is construction of a 450,000-sf to 500,000-sf office facility, also in Morris Plains. Phase three consists of construction of a 160,000-sf research and development addition, including renovation of adjacent space for manufacturing support in Parsippany.